Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Tami

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Pharmacy|February 1, 1991
Recombinant interleukin-2 and the quest for FDA approvalJ A Tami
Pharmacotherapy|January 1, 1987
Immunology for the clinical pharmacistJ A Tami
American Pharmacy|February 1, 1991
Recombinant DNA technology and therapeuticsJ A Tami
Drug Intelligence & Clinical Pharmacy|March 1, 1988
Metoclopramide suppository considerationsJ A Tami, W W Waite
Pharmacotherapy|January 1, 1992
Introduction to immunologyW J McIntyre, J A Tami
Annals of the New York Academy of Sciences|January 1, 1988
Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptorJ A Tami, K A Krolick
American Journal of Hospital Pharmacy|October 1, 1986
The immune systemJ A Tami, M D Parr, J S Thompson
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1987
T cell hybridomas reactive with the acetylcholine receptor and its subunitsJ A Tami, O E Urso, K A Krolick
Drug and Chemical Toxicology|January 1, 1992
Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravisT M Yeh, J A Tami, K A Krolick
Gut|October 14, 2004
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitisS J H van Deventer, J A Tami, M K Wedel
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacy|February 1, 1991
Recombinant interleukin-2 and the quest for FDA approvalJ A Tami
Pharmacotherapy|January 1, 1987
Immunology for the clinical pharmacistJ A Tami
American Pharmacy|February 1, 1991
Recombinant DNA technology and therapeuticsJ A Tami
Drug Intelligence & Clinical Pharmacy|March 1, 1988
Metoclopramide suppository considerationsJ A Tami, W W Waite
Pharmacotherapy|January 1, 1992
Introduction to immunologyW J McIntyre, J A Tami
Annals of the New York Academy of Sciences|January 1, 1988
Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptorJ A Tami, K A Krolick
American Journal of Hospital Pharmacy|October 1, 1986
The immune systemJ A Tami, M D Parr, J S Thompson
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1987
T cell hybridomas reactive with the acetylcholine receptor and its subunitsJ A Tami, O E Urso, K A Krolick
Drug and Chemical Toxicology|January 1, 1992
Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravisT M Yeh, J A Tami, K A Krolick
Gut|October 14, 2004
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitisS J H van Deventer, J A Tami, M K Wedel
Pageof 2